CD8A and neoplasm: Ectopic introduction of necroptotic cells to the tumor microenvironment promotes BATF3+CDC1− and CD8+ leukocyte-dependent antitumor immunity accompanied by increased tumor antigen loaded by tumor-associated antigen-presenting cells [119].